(Q39017211)

8 September 2017

title

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models (English)

1 reference

8 September 2017

1 reference

1 reference

Bo Mi Ku

1

1 reference

8 September 2017

Se-Jin Kim

2

1 reference

8 September 2017

Nayeon Kim

3

1 reference

8 September 2017

Dongwan Hong

4

1 reference

8 September 2017

Yong-Bock Choi

5

1 reference

8 September 2017

Seon-Hyeong Lee

6

1 reference

8 September 2017

Young-Dae Gong

7

1 reference

8 September 2017

Soo-Youl Kim

8

1 reference

8 September 2017

publication date

8 March 2014

1 reference

Journal of Cancer Research and Clinical Oncology

8 September 2017

published in

1 reference

8 September 2017

volume

140

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

757-767

1 reference

NCBI GEO: archive for functional genomics data sets--update

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Combinatorial syntheses of five-membered ring heterocycles using carbon disulfide and a solid support

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Sorafenib and everolimus in advanced clear cell renal carcinoma: a phase I/II trial of the SCRI Oncology Research Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Activation of extracellular transglutaminase 2 by thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Phytochemicals and protein-polyamine conjugates by transglutaminase as chemopreventive and chemotherapeutic tools in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

The epidemiology of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Targeted-therapy in advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

ONCOMINE: a cancer microarray database and integrated data-mining platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Transglutaminase 2 inhibitors and their therapeutic role in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Redox regulation of transglutaminase 2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1623-5

Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase

21 January 2018

1 reference

12 December 2020

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy

1 reference

12 December 2020

A Peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice

1 reference

12 December 2020

VEGF inhibitors in metastatic renal cell carcinoma: current therapies and future perspective

1 reference

12 December 2020

Gene signatures of progression and metastasis in renal cell cancer

1 reference

12 December 2020

Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis

1 reference

12 December 2020

10.1007/S00432-014-1623-5

Identifiers

DOI

1 reference

release_a5iicwecsvfnlhmgjsq3x7fhi4

8 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a5iicwecsvfnlhmgjsq3x7fhi4

24 November 2022

mapped directly with Wikidata item

1 reference